BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
6.03
+0.02 (0.33%)
At close: Aug 1, 2025, 4:00 PM
6.10
+0.07 (1.16%)
After-hours: Aug 1, 2025, 7:23 PM EDT
Accolade Market Cap
BioVie has a market cap or net worth of $11.18 million as of August 1, 2025. Its market cap has decreased by -59.19% in one year.
Market Cap
11.18M
Enterprise Value
-11.60M
1-Year Change
-59.19%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $11.18M, a decrease of -78.50%. That is a compound annual growth rate of -27.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 11.10M | -68.73% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |